Andrew J Moss1, Hussein Tuffaha2, Arshad Malik3. 1. Department of Surgery, Peterborough City Hospital, Peterborough, Cambridgeshire, PE3 9GZ, UK. 2. Department of Surgery, Ipswich Hospital NHS Trust, Ipswich, IP4 5PD, UK. dmohell@yahoo.com. 3. Department of Surgery, Ipswich Hospital NHS Trust, Ipswich, IP4 5PD, UK.
Abstract
PURPOSE: Lower gastrointestinal (GI) bleeding is defined as bleeding distal to the ligament of Treitz. In the UK, it represents approximately 3 % of all surgical referrals to the hospital. This review aims to provide review of the current evidence regarding the management of this condition. METHODS: Literature was searched using Medline, Pubmed, and Cochrane for relevant evidence by two researchers. This was conducted in a manner that enabled a narrative review of the evidence covering the aetiology, clinical assessment and management options of continuously bleeding patients. FINDINGS: The majority of patients with acute lower GI bleeding can be treated conservatively. In cases where ongoing bleeding occurs, colonoscopy is still the first line of investigation and treatment. Failure of endoscopy and persistent instability warrant angiography, possibly preceded by CT angiography and proceeding to superselective embolisation. Failure of embolisation warrants surgical intervention. CONCLUSIONS: There are still many unanswered questions. In particular, the development of a more reliable predictive tool for mortality, rebleeding and requirement for surgery needs to be the ultimate priority. There are a small number of encouraging developments on combination therapy with regard to angiography, endoscopy and surgery. Additionally, the increasing use of haemostatic agents provides an additional tool for the management of bleeding endoscopically in difficult situations.
PURPOSE: Lower gastrointestinal (GI) bleeding is defined as bleeding distal to the ligament of Treitz. In the UK, it represents approximately 3 % of all surgical referrals to the hospital. This review aims to provide review of the current evidence regarding the management of this condition. METHODS: Literature was searched using Medline, Pubmed, and Cochrane for relevant evidence by two researchers. This was conducted in a manner that enabled a narrative review of the evidence covering the aetiology, clinical assessment and management options of continuously bleedingpatients. FINDINGS: The majority of patients with acute lower GI bleeding can be treated conservatively. In cases where ongoing bleeding occurs, colonoscopy is still the first line of investigation and treatment. Failure of endoscopy and persistent instability warrant angiography, possibly preceded by CT angiography and proceeding to superselective embolisation. Failure of embolisation warrants surgical intervention. CONCLUSIONS: There are still many unanswered questions. In particular, the development of a more reliable predictive tool for mortality, rebleeding and requirement for surgery needs to be the ultimate priority. There are a small number of encouraging developments on combination therapy with regard to angiography, endoscopy and surgery. Additionally, the increasing use of haemostatic agents provides an additional tool for the management of bleeding endoscopically in difficult situations.
Entities:
Keywords:
Colonoscopy; Endoscopy; GI angiography; GI bleeding; GI haemorrhage; Haematochezia; Lower GI
Authors: Constantine A Soulellis; Stephanie Carpentier; Yen-I Chen; Carlo A Fallone; Alan N Barkun Journal: Gastrointest Endosc Date: 2013-01-03 Impact factor: 9.427
Authors: Ker-Kan Tan; Timothy Shore; David Hung Strong; Mohammad Rafei Ahmad; Richard C Waugh; Christopher John Young Journal: Int J Colorectal Dis Date: 2013-07-09 Impact factor: 2.571
Authors: Ali Y Mejaddam; Catrina M Cropano; Sanjeeva Kalva; T Gregory Walker; Ayesha M Imam; George C Velmahos; Marc A de Moya; David R King Journal: J Trauma Acute Care Surg Date: 2013-09 Impact factor: 3.313
Authors: Min Seob Kwak; Jae Myung Cha; Yong Jae Han; Jin Young Yoon; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Joung Il Lee Journal: J Korean Med Sci Date: 2016-10 Impact factor: 2.153